Skip to content

Decipher Genomic Testing Enables Personalized Treatment Planning for Urologic Cancers

At Veracyte, we are dedicated to the continued pursuit of evidence for our Decipher genomic tests, which help in making treatment decisions for prostate and bladder cancers.

Decipher is the Most Validated Tissue-based Gene Expression Test in Prostate Cancer
Learn More:

Decipher Prostate is a tissue-based genomic test that provides actionable information for treatment decision-making across the spectrum of localized prostate cancer.

Decipher Bladder is the only commercially available genomic subtyping tool for patients with bladder cancer to help inform key treatment decisions.

Learn about Veracyte